Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $39.7000 (-2.7%) ($39.0000 - $41.1000) on Wed. Mar. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.82% (three month average) | RSI | 60 | Latest Price | $39.7000(-2.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -3.41% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-5%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.41% (StdDev 6.82%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
Resistance Level | $41.82 | 5 Day Moving Average | $40.59(-2.19%) | 10 Day Moving Average | $41.94(-5.34%) | 20 Day Moving Average | $41.82(-5.07%) | To recent high | -17.9% | To recent low | 160.3% | Market Cap | $2.95b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |